Literature DB >> 2178532

Receptors and intracellular signaling in human neutrophils.

P D Lew1.   

Abstract

Adherence, chemotaxis, phagocytosis, and responses to cytokines are mediated by distinct classes of cell surface receptors in human neutrophils. Intracellular signaling by these different receptors is a subject of active investigation. Observation of single neutrophils adherent to surfaces reveals the presence of spontaneous oscillations of cytosolic-free calcium, [Ca2+]i, generated by mechanisms that are presently unknown. Chemoattractant receptor activation via a specific G-regulatory protein activates a plasma membrane phospholipase C and generates diacylglycerol and inositol(1,4,5)triphosphate. DG activates C kinase(s). Ins(1,4,5)P3 releases Ca2+ from a specific intracellular organelle, the calciosome. Calciosomes resemble sarcoplasmic reticulum: they contain a Ca2(+)-ATPase and a high capacity/low affinity calcium-binding, calsequestrin-like protein. Chemoattractant receptor stimulation of calcium influx across the plasma membrane in phagocytes correlates strongly with the conversion of Ins(1,3,4,5)P3 to Ins(1,3,4,5)P4 by a Ca2(+)-calmodulin-sensitive kinase. The transduction system of phagocytosis receptors also generates DG and Ins(1,4,5)P3 and elicits [Ca2+]i elevations. The Ca2+ signal is an important regulator of secretion (granule exocytosis, superoxide production), whereas C kinase(s)/and other unknown mediators appear to be more important for the control of movement. Several mechanisms that could account for the specificity of cell signaling by different receptors are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2178532     DOI: 10.1164/ajrccm/141.3_Pt_2.S127

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

Review 1.  The selectins: insights into selectin-induced intracellular signaling in leukocytes.

Authors:  E Crockett-Torabi; J C Fantone
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

2.  Effect of adhesion on inducible nitric oxide synthase (iNOS) production in purified human neutrophils.

Authors:  J L Webb; J M Polak; T J Evans
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

3.  Activation of Neutrophils via IP3 Pathway Following Exposure to Demodex-Associated Bacterial Proteins.

Authors:  Fred McMahon; Nessa Banville; David A Bergin; Christian Smedman; Staffan Paulie; Emer Reeves; Kevin Kavanagh
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

Review 4.  Invertebrate phosphatidylinositol-specific phospholipases C and their role in cell signaling.

Authors:  R D Shortridge; R R McKay
Journal:  Invert Neurosci       Date:  1995-12

5.  Directed neutrophil migration to IL-8 is increased in cystic fibrosis: a study of the effect of erythromycin.

Authors:  S Brennan; D Cooper; P D Sly
Journal:  Thorax       Date:  2001-01       Impact factor: 9.139

6.  Calicum microdomains form within neutrophils at the neutrophil-tumor cell synapse: role in antibody-dependent target cell apoptosis.

Authors:  Andrea J Clark; Michelle Diamond; Megan Elfline; Howard R Petty
Journal:  Cancer Immunol Immunother       Date:  2009-07-11       Impact factor: 6.968

7.  Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase.

Authors:  C C Silliman; K L Clay; G W Thurman; C A Johnson; D R Ambruso
Journal:  J Lab Clin Med       Date:  1994-11

8.  Immunomodulatory activity of oenothein B isolated from Epilobium angustifolium.

Authors:  Igor A Schepetkin; Liliya N Kirpotina; Larissa Jakiw; Andrei I Khlebnikov; Christie L Blaskovich; Mark A Jutila; Mark T Quinn
Journal:  J Immunol       Date:  2009-10-21       Impact factor: 5.422

9.  Neutrophils from asthmatics exhibit diminished responsiveness to 2-chloroadenosine which is reversed by theophylline. Evidence for a cyclic-AMP-independent pathway on human neutrophils.

Authors:  B Z Joseph; A M Sustiel; L Borish
Journal:  Inflammation       Date:  1992-04       Impact factor: 4.092

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.